Literature DB >> 3398543

The modified Fontan operation for asplenia and polysplenia syndromes.

R A Humes1, R H Feldt, C J Porter, P R Julsrud, F J Puga, G K Danielson.   

Abstract

From 1975 through 1986, 49 patients with asplenia (23 patients) or polysplenia (26 patients) syndromes underwent a modified Fontan operation. All patients had anomalous systemic venous return, and 43 (88%) had anomalous pulmonary venous return. The atrioventricular valve anatomy varied: 36 patients had a common atrial chamber and common atrioventricular valve, eight had mitral valve atresia, and five had severe mitral valve hypoplasia. Redirection of systemic venous return was accomplished by (1) atrial baffle (29 patients), (2) intraatrial conduit (19 patients), and (3) extraatrial conduit (one patient). There were 21 (43%) hospital deaths overall. However, since 1985, six of 22 patients (27%) have died. Increased mortality was seen in patients requiring atrioventricular valve repair or replacement (8/11, 73%) and in patients with asplenia (65%). Lower mortality was seen in patients with polysplenia (24%) and those receiving an intraatrial conduit (26%), although this decrease also represents the more recent experience. We conclude: (1) The Fontan operation for patients with asplenia or polysplenia syndromes has resulted in a significant (although recently declining) mortality; (2) mortality is higher in patients with asplenia; (3) patients with atrioventricular valve insufficiency requiring repair or replacement are at higher risk; and (4) intraatrial conduits seem to offer promise for successfully accomplishing this repair.

Entities:  

Mesh:

Year:  1988        PMID: 3398543

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  A staged Fontan approach in patients initially unsuitable for the primary Fontan procedure.

Authors:  H Uemura; T Yagihara; Y Kawahira; K Yoshizumi; Y Yoshikawa; S Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-06

2.  Recent modifications of the fontan procedure for complex congenital heart disease.

Authors:  G J Reul; I D Gregoric
Journal:  Tex Heart Inst J       Date:  1992

Review 3.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

4.  Development of a thermodynamic control system for the Fontan circulation pulsation device using shape memory alloy fibers.

Authors:  Akihiro Yamada; Yasuyuki Shiraishi; Hidekazu Miura; Hashem Mohamed Omran Hashem; Yusuke Tsuboko; Masaaki Yamagishi; Tomoyuki Yambe
Journal:  J Artif Organs       Date:  2015-04-18       Impact factor: 1.731

Review 5.  Arrhythmias After Fontan Operation with Intra-atrial Lateral Tunnel Versus Extra-cardiac Conduit: A Systematic Review and Meta-analysis.

Authors:  Dongxu Li; Qiang Fan; Yasutaka Hirata; Minoru Ono; Qi An
Journal:  Pediatr Cardiol       Date:  2017-03-07       Impact factor: 1.655

6.  Modified Fontan procedure for left atrial isomerism: alternative technique.

Authors:  E R Rosenkranz; D J Murphy
Journal:  Pediatr Cardiol       Date:  1995 Jul-Aug       Impact factor: 1.655

7.  The earliest site of atrial activation in patients with isomeric appendages.

Authors:  H Uemura; T Yagihara; Y Kawashima; K Okada; R H Anderson
Journal:  Br Heart J       Date:  1995-09

8.  Maximal hemodynamic response after the Fontan procedure: Doppler evaluation during the treadmill test.

Authors:  R G Cortes; G Satomi; M Yoshigi; K Momma
Journal:  Pediatr Cardiol       Date:  1994 Jul-Aug       Impact factor: 1.655

9.  Importance of totally anomalous pulmonary venous connection and postoperative pulmonary vein stenosis in outcomes of heterotaxy syndrome.

Authors:  Susan R Foerster; Kimberlee Gauvreau; Doff B McElhinney; Tal Geva
Journal:  Pediatr Cardiol       Date:  2007-11-15       Impact factor: 1.655

10.  Association of hiatus hernia with asplenia syndrome.

Authors:  J K Wang; M H Chang; Y W Li; W J Chen; H C Lue
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.